血漿分画の世界市場レポート 2025年

血漿分画の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.6%で515億6,000万米ドルに成長します。予測期間の成長は、世界のヘルスケア支出の増加、血漿由来医薬品の用途拡大、研究開発投資の増加、神経疾患治療における血漿需要、血漿分画施設の拡張などに起因しています。予測期間における主な動向としては、新しい分画技術の開発、アルブミンや免疫グロブリン治療へのシフト、特殊血漿製品の需要増加、病原体不活化技術への注力、血漿業界における戦略的提携やパートナーシップなどが挙げられます。

慢性疾患の増加が予想され、血漿分画市場の成長を牽引します。慢性疾患とは、1年以上持続し、継続的な医学的治療を必要とするもので、心臓病、がん、糖尿病などの疾患が含まれます。血漿製品による慢性疾患患者の治療は、罹患率を低下させるだけでなく、生活の質を高め、費用対効果が高いことが証明されています。国立医学図書館の報告によると、2050年までに、50歳以上で1つ以上の慢性疾患を持つ人々が99.5％増加し、米国では1億4,266万人に達する見込みです。2020年は7,152万2,000人でした。すべての年齢層における慢性疾患患者の急増は、血漿分画市場の成長を促進すると予想されます。

血友病の有病率の増加は、血漿分画市場の重要な促進要因になると予測されます。血友病は血液凝固に影響を及ぼすまれな遺伝性疾患で、出血の長期化につながります。血漿分画は、血液凝固を促進するために血友病患者に投与される凝固因子の生産に不可欠です。世界血友病連盟によると、世界で毎年約2万人の血友病患者が報告されており、そのうち7,000人は重症例です。現在の世界の男性人口39億人のうち、血友病患者は81万8,928人と推定されます。このように、血友病の有病率の増加は、血漿分画市場を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の血漿分画市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の血漿分画市場：成長率分析
• 世界の血漿分画市場の実績：規模と成長、2019～2024年
• 世界の血漿分画市場の予測：規模と成長、2024～2029年、2034年
• 世界の血漿分画総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血漿分画市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 免疫グロブリン
• 凝固因子
• アルブミン
• プロテアーゼ阻害剤
• 世界の血漿分画市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 免疫学
• 血液学
• 神経学
• 集中治療
• 血液腫瘍学
• リウマチ学
• 世界の血漿分画市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院・クリニック
• 臨床研究ラボ
• 学術機関
• 世界の血漿分画市場：免疫グロブリンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈内免疫グロブリン（IVIG）
• 皮下免疫グロブリン（SCIG）
• 世界の血漿分画市場：凝固因子のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 第VIII因子
• 第IX因子
• プロトロンビン複合体濃縮物（PCC）
• 世界の血漿分画市場：アルブミンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒトアルブミン
• ウシ血清アルブミン（BSA）
• 世界の血漿分画市場：プロテアーゼ阻害剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• α-1アンチトリプシン（AAT）
• C1エステラーゼ阻害剤（C1-INH）

第7章 地域別・国別分析

• 世界の血漿分画市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の血漿分画市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血漿分画市場：競合情勢
• 血漿分画市場：企業プロファイル
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis
  • Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • CSL Limited Overview, Products and Services, Strategy and Financial Analysis
  • Grifols S. A Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• ADMA Biologics Inc.
• Green Cross Corporation
• Hualan Bioengineering Inc.
• Intas Pharmaceuticals Ltd.
• Japan Blood Products Organization
• Kedrion S. P. A.
• Kamada Ltd.
• LFB Biomedicaments S. A. S
• Octapharma AG
• Sanquin Plasma Products B. V.
• Shanghai Raas Blood Products Co. Ltd.
• Takeda Pharmaceutical Company
• Terumo BCT
• China Biologic Products Holdings Inc.
• China National Biotec Group

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血漿分画市場2029：新たな機会を提供する国
• 血漿分画市場2029：新たな機会を提供するセグメント
• 血漿分画市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Plasma fractionation is the process of integrating manufacturing procedures to sequentially isolate crude fractions, which are then further refined into specific medicinal products.

The primary products in the plasma fractionation market include immunoglobulins, coagulation factors, albumin, and protease inhibitors. Immunoglobulins find application in treating a wide range of disorders, encompassing primary and secondary immune deficiencies, autoimmune diseases, and inflammatory conditions. Immunoglobulins (Ig) and antibodies, glycoproteins produced by plasma cells, play a crucial role in the immune system's recognition and neutralization of foreign objects such as pathogenic bacteria and viruses. These products have various applications in immunology, hematology, neurology, critical care, hemato-oncology, and rheumatology, with end users spanning hospitals and clinics, clinical research laboratories, and academic institutes.

The plasma fractionation market research report is one of a series of new reports from The Business Research Company that provides plasma fractionation market statistics, including plasma fractionation industry global market size, regional shares, competitors with an plasma fractionation market share, detailed plasma fractionation market segments, market trends and opportunities, and any further data you may need to thrive in the plasma fractionation industry. This plasma fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma fractionation market size has grown strongly in recent years. It will grow from $31.42 billion in 2024 to $34.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to growing prevalence of hemophilia and immunodeficiency disorders, increased aging population, rising demand for immunoglobulins, expansion of plasma collection centers, growing number of surgical procedures.

The plasma fractionation market size is expected to see rapid growth in the next few years. It will grow to $51.56 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising global healthcare expenditure, growing applications of plasma-derived medicinal products, increasing investment in research and development, demand for plasma in the treatment of neurological disorders, expansion of plasma fractionation facilities. Major trends in the forecast period include development of new fractionation technologies, shift towards albumin and immunoglobulin therapies, rising demand for specialty plasma products, focus on pathogen inactivation technologies, strategic collaborations and partnerships in the plasma industry.

The anticipated increase in the number of chronic diseases is set to drive the growth of the plasma fractionation market. Chronic diseases, lasting one year or more and requiring ongoing medical attention, include conditions like heart disease, cancer, and diabetes. The treatment of chronic disease patients through plasma products not only reduces morbidity but also enhances the quality of life and proves to be cost-effective. A report by the National Library of Medicine projects a 99. 5% rise in individuals aged 50 years and older with one or more chronic illnesses by 2050, reaching 142. 66 million, up from 71. 522 million in 2020 in the United States. The surge in chronic disease cases across all age groups is expected to fuel the growth of the plasma fractionation market.

The increasing prevalence of hemophilia is poised to be a significant driver for the plasma fractionation market. Hemophilia, a rare genetic disorder affecting blood clotting, leads to prolonged bleeding episodes. Plasma fractionation is vital for producing clotting factors administered to individuals with hemophilia to facilitate blood coagulation. According to the World Federation of Hemophilia, approximately 20,000 people with hemophilia are born globally each year, with 7,000 having severe cases. In the current global male population of 3. 9 billion, there are an estimated 818,928 hemophilia patients. Thus, the growing prevalence of hemophilia is expected to propel the plasma fractionation market.

Major companies in the market are introducing new technologies, such as high-tech facility processes that convert donated human plasma into essential medicines while utilizing advanced technology to enhance efficiency and safety. For example, in March 2023, CSL Behring, a German-based company, opened a new $470 million plasma fractionation facility that employs cutting-edge technology to improve the efficiency and safety of plasma processing, ensuring the production of higher quality and more reliable medicines. This facility addresses the increasing demand for these critical medicines, making life-saving treatments more accessible to patients. With advanced automation and self-cleaning systems in place, the facility minimizes the risk of contamination and improves overall hygienic conditions, thereby enhancing patient safety.

Strategic investments in expanding manufacturing capabilities for plasma-derived therapies (PDTs) are a focus for major players in the industry. This involves allocating resources to develop and enhance facilities and processes for the production of specialized therapies derived from blood plasma. In April 2023, Takeda Pharmaceutical, a Japan-based biopharmaceutical company, invested ¥100 billion (approximately $755. 8 million) to construct a state-of-the-art plasma-derived therapy manufacturing facility in Osaka. With a commitment to environmental sustainability, Takeda aims to achieve net-zero greenhouse gas emissions in its operations by 2035.

In April 2022, Grifols S. A., a Spain-based pharmaceutical and chemical product manufacturing company, completed the acquisition of Biotest AG for $317. 03 million (EUR 318 million). Through this strategic move, Grifols aims to enhance the availability of plasma medicines, expand its product line, and strengthen its position as the largest private European network of plasma facilities with 87 locations. The acquisition is expected to drive revenue growth, profitability expansion, and accelerate the advancement of research and development projects.

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

North America was the largest region in the plasma fractionation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the plasma fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The plasma fractionation market includes revenues earned by entities by combining manufacturing steps to isolate, in a sequential and integrated manner. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Fractionation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasma fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plasma fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Immunoglobulins; Coagulation Factors; Albumin; Protease Inhibitors
• 2) By Application: Immunology; Hematology; Neurology; Critical Care; Hemato-Oncology; Rheumatology
• 3) By End User: Hospitals and Clinics; Clinical Research Laboratories; Academic Institutes
• Subsegments:
• 1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
• 2) By Coagulation Factors: Factor VIII; Factor IX; Prothrombin Complex Concentrates (PCC)
• 3) By Albumin: Human Albumin; Bovine Serum Albumin (BSA)
• 4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT); C1 Esterase Inhibitor (C1-INH)
• Companies Mentioned: Baxter International Inc.; Bio Products Laboratory Limited; Biotest AG; CSL Limited; Grifols S. A
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plasma Fractionation Market Characteristics

3. Plasma Fractionation Market Trends And Strategies

4. Plasma Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Plasma Fractionation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plasma Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plasma Fractionation Market Growth Rate Analysis
• 5.4. Global Plasma Fractionation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plasma Fractionation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plasma Fractionation Total Addressable Market (TAM)

6. Plasma Fractionation Market Segmentation

• 6.1. Global Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoglobulins
• Coagulation Factors
• Albumin
• Protease Inhibitors
• 6.2. Global Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunology
• Hematology
• Neurology
• Critical Care
• Hemato-Oncology
• Rheumatology
• 6.3. Global Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes
• 6.4. Global Plasma Fractionation Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Immunoglobulin (IVIG)
• Subcutaneous Immunoglobulin (SCIG)
• 6.5. Global Plasma Fractionation Market, Sub-Segmentation Of Coagulation Factors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Factor VIII
• Factor IX
• Prothrombin Complex Concentrates (PCC)
• 6.6. Global Plasma Fractionation Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Albumin
• Bovine Serum Albumin (BSA)
• 6.7. Global Plasma Fractionation Market, Sub-Segmentation Of Protease Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alpha-1 Antitrypsin (AAT)
• C1 Esterase Inhibitor (C1-INH)

7. Plasma Fractionation Market Regional And Country Analysis

• 7.1. Global Plasma Fractionation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plasma Fractionation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plasma Fractionation Market

• 8.1. Asia-Pacific Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plasma Fractionation Market

• 9.1. China Plasma Fractionation Market Overview
• 9.2. China Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plasma Fractionation Market

• 10.1. India Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plasma Fractionation Market

• 11.1. Japan Plasma Fractionation Market Overview
• 11.2. Japan Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plasma Fractionation Market

• 12.1. Australia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plasma Fractionation Market

• 13.1. Indonesia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plasma Fractionation Market

• 14.1. South Korea Plasma Fractionation Market Overview
• 14.2. South Korea Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plasma Fractionation Market

• 15.1. Western Europe Plasma Fractionation Market Overview
• 15.2. Western Europe Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plasma Fractionation Market

• 16.1. UK Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plasma Fractionation Market

• 17.1. Germany Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plasma Fractionation Market

• 18.1. France Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plasma Fractionation Market

• 19.1. Italy Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plasma Fractionation Market

• 20.1. Spain Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plasma Fractionation Market

• 21.1. Eastern Europe Plasma Fractionation Market Overview
• 21.2. Eastern Europe Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plasma Fractionation Market

• 22.1. Russia Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plasma Fractionation Market

• 23.1. North America Plasma Fractionation Market Overview
• 23.2. North America Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plasma Fractionation Market

• 24.1. USA Plasma Fractionation Market Overview
• 24.2. USA Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plasma Fractionation Market

• 25.1. Canada Plasma Fractionation Market Overview
• 25.2. Canada Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plasma Fractionation Market

• 26.1. South America Plasma Fractionation Market Overview
• 26.2. South America Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plasma Fractionation Market

• 27.1. Brazil Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plasma Fractionation Market

• 28.1. Middle East Plasma Fractionation Market Overview
• 28.2. Middle East Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plasma Fractionation Market

• 29.1. Africa Plasma Fractionation Market Overview
• 29.2. Africa Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plasma Fractionation Market Competitive Landscape And Company Profiles

• 30.1. Plasma Fractionation Market Competitive Landscape
• 30.2. Plasma Fractionation Market Company Profiles
  • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. CSL Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Grifols S. A Overview, Products and Services, Strategy and Financial Analysis

31. Plasma Fractionation Market Other Major And Innovative Companies

• 31.1. ADMA Biologics Inc.
• 31.2. Green Cross Corporation
• 31.3. Hualan Bioengineering Inc.
• 31.4. Intas Pharmaceuticals Ltd.
• 31.5. Japan Blood Products Organization
• 31.6. Kedrion S. P. A.
• 31.7. Kamada Ltd.
• 31.8. LFB Biomedicaments S. A. S
• 31.9. Octapharma AG
• 31.10. Sanquin Plasma Products B. V.
• 31.11. Shanghai Raas Blood Products Co. Ltd.
• 31.12. Takeda Pharmaceutical Company
• 31.13. Terumo BCT
• 31.14. China Biologic Products Holdings Inc.
• 31.15. China National Biotec Group

32. Global Plasma Fractionation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plasma Fractionation Market

34. Recent Developments In The Plasma Fractionation Market

35. Plasma Fractionation Market High Potential Countries, Segments and Strategies

• 35.1 Plasma Fractionation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plasma Fractionation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plasma Fractionation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer